- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04562259
Verification of Kimmerle's Anomaly by X-ray Methods of Research
September 18, 2020 updated by: Samarkand State Medical Institute
Kimmerle's anomaly is a bony bridge over the posterior arch of the first cervical vertebra that forms a bony ring.
The vertebral artery passes through the opening.
This bone bridge could theoretically be an extravasal compression of the artery and disrupt the normal blood flow to the brain.
Evaluating the data of X-ray methods, determine the frequency of occurrence and types of Kimmerle anomaly.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
It is planned to conduct an examination of 30 patients on the basis of the Department of Radiation Diagnostics and Therapy of the Samarkand State Medical Institute.
Patients of all ages will be examined, directed by doctors for computed tomography of the brain with the capture of the upper cervical spine and the cervical spine.
with complaints of headache, dizziness, pain in the cervical region Among those who have passed the study, it is necessary to identify patients with Kimmerle's anomaly and determine the age at which it often occurs, whether it is a congenital pathology or the result of degenerative-dystrophic changes.
It is also planned to calculate the frequency of occurrence among the population, the type of this pathology (complete and incomplete bone bridge, right-sided and left-sided location), the size of the hole formed.
The condition of the posterior parts of the brain will be assessed in the presence of Kimmerle's anomaly on a CT scan.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Samarkand, Uzbekistan, 140100
- Samarkand State Medical Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients of all ages will be examined, directed by doctors for computed tomography of the brain with the capture of the upper cervical spine and the cervical spine.
with complaints of headache, dizziness, pain in the cervical region
Description
Inclusion Criteria:
- Patients with Kimmerle's anomaly
Exclusion Criteria:
- patients in whom the structure of the first cervical vertebra is not clearly visible
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients with Kimmerle's anomaly
patients who have a complete or incomplete bony bridge over the posterior arch of the first cervical vertebra
|
In patients with Kimmerle's anomaly, using computed tomography of the brain with the capture of the upper cervical spine and cervical spine, it is planned to determine at what age this pathology is more common, localization of the anomaly (right, left), complete or incomplete form of the anomaly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
In patients with Kimmerle anomaly, determine the types of forms of this pathology
Time Frame: up to 36 months
|
In patients with Kimmerle's anomaly, using computed tomography of the brain with the capture of the upper cervical spine and cervical spine, it is planned to determine at what age this pathology is more common, localization of the anomaly (right, left), complete or incomplete form of the anomaly.
|
up to 36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Gulshod Mardieva, docent, Samarkand State Medical Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Anticipated)
December 31, 2026
Study Completion (Anticipated)
December 31, 2026
Study Registration Dates
First Submitted
September 18, 2020
First Submitted That Met QC Criteria
September 18, 2020
First Posted (Actual)
September 24, 2020
Study Record Updates
Last Update Posted (Actual)
September 24, 2020
Last Update Submitted That Met QC Criteria
September 18, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Project#3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kimmerle's Anomaly
-
Samarkand State Medical InstituteActive, not recruiting
-
University of California, San DiegoWithdrawnMajor Fetal AnomalyUnited States
-
University Hospital, GhentRecruitingMullerian Anomaly of Uterus, Nec | Mullerian Anomaly of Vagina | Mullerian Anomaly of CervixBelgium
-
University Hospital, GhentRecruitingMullerian Anomaly of Uterus, Nec | Mullerian Anomaly of Vagina | Mullerian Anomaly of CervixBelgium
-
Sohag UniversityNot yet recruiting
-
Samuel Lunenfeld Research Institute, Mount Sinai...WithdrawnPsychological Sequelae of Termination of Pregnancy for Fetal AnomalyCanada
-
Washington University School of MedicineNational Cancer Institute (NCI)Recruiting
-
University of BaghdadCompletedTeeth; Anomaly, PositionIraq
-
Wake Forest University Health SciencesRecruitingCongenital Mullerian Duct AnomalyUnited States
-
University of the Western CapeCompletedAnomaly of Dental ArchSouth Africa
Clinical Trials on Verification of Kimmerle's anomaly by x-ray methods of research
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPostural Tachycardia Syndrome (POTS)United States
-
Central Hospital, Nancy, FranceCompleted
-
San Diego State UniversityCompletedFetal Alcohol Spectrum Disorders | Prenatal Alcohol Exposure | Fetal Alcohol Syndrome | Partial Fetal Alcohol Syndrome | Alcohol-related Neurodevelopmental DisorderUnited States
-
University of MichiganRecruiting
-
National Cancer Institute (NCI)RecruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada